These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24603587)

  • 1. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
    Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
    Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
    Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
    Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
    Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
    Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
    Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
    Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
    van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
    Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare expression of T-cell markers in classical Hodgkin's lymphoma.
    Tzankov A; Bourgau C; Kaiser A; Zimpfer A; Maurer R; Pileri SA; Went P; Dirnhofer S
    Mod Pathol; 2005 Dec; 18(12):1542-9. PubMed ID: 16056244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
    Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
    N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas.
    Bai M; Papoudou-Bai A; Horianopoulos N; Grepi C; Agnantis NJ; Kanavaros P
    Hum Pathol; 2007 Jan; 38(1):103-13. PubMed ID: 16949642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
    Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
    Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
    Smolewski P; Niewiadomska H; Los E; Robak T
    Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phase.
    Tiemann M; Claviez A; Lüders H; Zimmermann M; Schellong G; Dörffel W; Parwaresch R
    Mod Pathol; 2005 Nov; 18(11):1440-7. PubMed ID: 16056247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
    Kim LH; Nadarajah VS; Peh SC; Poppema S
    Histopathology; 2004 Mar; 44(3):257-67. PubMed ID: 14987230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
    Koh YW; Jeon YK; Yoon DH; Suh C; Huh J
    Tumour Biol; 2016 Jun; 37(6):7507-14. PubMed ID: 26678894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications.
    Martín P; Salas C; Provencio M; Abraira V; Bellas C
    Leuk Lymphoma; 2011 Nov; 52(11):2162-8. PubMed ID: 21749309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
    Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Viviani S; Bonfante V; Nadali G; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McDonnell TJ; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Blood; 2002 Dec; 100(12):3935-41. PubMed ID: 12433696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.